CMTA_2020_Annual_Report
…Target Discovery Discovery 1A Discovery Research Tools Preclinical Phase1 Phase2 Phase3 10 11 32+ Research Partners 50+ Research Projects $17M+ in Research Funding D E M Y E L I…
The_2018_CMTA_Report_35th_Anniversary_Edition
…picture of how prevalent CMT actually is. • Influences and perhaps changes the direction CMT research will take. • Stimulates research interest and attracts more research funds. • Speeds up…
The_2018_CMTA_Report_35th_Anniversary_Edition
…picture of how prevalent CMT actually is. • Influences and perhaps changes the direction CMT research will take. • Stimulates research interest and attracts more research funds. • Speeds up…
Help_for_Today_2-2017
…research within the CMT community, and it is the only CMT-specific patient advocacy organization in the United States strategically aligned with the National Institutes of Health Rare Disease Clinical Research…
Help_for_Today_2-2017
…research within the CMT community, and it is the only CMT-specific patient advocacy organization in the United States strategically aligned with the National Institutes of Health Rare Disease Clinical Research…
2018_CMTA_Annual_Report_2
…is a non-profit organization dedicated to finding a cure for CMT. The CMTA’s Strategy to Accelerate Research (STAR) program brings top researchers together with pharmaceutical and biotechnology partners and patients…
2017_Fall_CMTA_Report
…to walk, run, dance and enjoy life to the fullest.” CMT1A research is part of CMTA’s Strategy to Accelerate Research (STAR) program that puts top researchers together with pharmaceutical partners—and…
CMTAreportSpring2022
…inform a more general therapeutic strategy for dominant CMT2E. All the CMTA’s research efforts are consolidated under the banner of STAR—which brings together the world’s largest network of biotech research…
2017_Fall_CMTA_Report
…to walk, run, dance and enjoy life to the fullest.” CMT1A research is part of CMTA’s Strategy to Accelerate Research (STAR) program that puts top researchers together with pharmaceutical partners—and…
CMTA Appoints Science and Technology Veteran, Patricia Verduin, PhD, to the Board of Directors
The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research aimed at bringing treatments and a cure to patients, is pleased to announce the appointment of a…